Cargando…
Extracorporeal membrane oxygenation support in patients with hematologic malignancies: to whom and when?
Autores principales: | Hong, Junshik, Choi, Chang Hyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Association of Internal Medicine
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5668400/ https://www.ncbi.nlm.nih.gov/pubmed/29056036 http://dx.doi.org/10.3904/kjim.2016.260 |
Ejemplares similares
-
Clinical outcomes of extracorporeal membrane oxygenation support in patients with hematologic malignancies
por: Kang, Hye Seon, et al.
Publicado: (2015) -
Antimicrobial Exposure: Do Not Forget the Patient’s Condition Beneath the Extracorporeal Membrane Oxygenation Support!
por: Fillatre, Pierre, et al.
Publicado: (2023) -
Extracorporeal Membrane Oxygenation Support for Incessant Tachyarrhythmia-Induced Severe Cardiogenic Shock
por: Zhang, Zhi-Ping, et al.
Publicado: (2018) -
Commentary: Extracorporeal membrane oxygenation (ECMO) in the coronavirus disease 2019 (COVID-19) pandemic; When, how, and to whom
por: Pyo, Won Kyung, et al.
Publicado: (2021) -
Association between Availability of Extracorporeal Membrane Oxygenation and Mortality in Patients with COVID-19 Eligible for Extracorporeal Membrane Oxygenation: A Natural Experiment
por: Gannon, Whitney D., et al.
Publicado: (2022)